Influenza enzyme and zanamivir drug. Molecular model of the neuraminidase glycoprotein enzyme from the surface of the influenza A virus, bound to the drug zanamivir. The function of this protein is to enable the flu virus to be released from the host cell. Zanamivir, marketed as Relenza, is a neuraminidase inhibitor. This enzyme is from the H1N1 strain of the flu virus.
| px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP15985291
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
artworkbiochemicalbiochemistrybiologicalbiologybiomoleculeconditioncutoutcutoutscut-outcut-outscutoutcutoutsdiseasedisorderdrugenzymefluglycoproteingraphich1n1illustrationinfluenzaamacromoleculemedicalmedicinemolecularbiologymolecularmodelmolecularstructuremoleculesneuraminidaseno-onenobodypharmaceuticalpharmaceuticspharmacologicalpharmacologyproteinproteinsproteomicsstructuraltreatmentviruswhitebackgroundzanamivir
aartworkbackgroundbiochemicalbiochemistrybiologicalbiologybiologybiomoleculeconditioncutcutcut-outcut-outscutoutcutoutsdiseasedisorderdrugenzymefluglycoproteingraphich1n1illustrationinfluenzamacromoleculemedicalmedicinemodelmolecularmolecularmolecularmoleculesneuraminidaseno-onenobodyoutoutspharmaceuticalpharmaceuticspharmacologicalpharmacologyproteinproteinsproteomicsstructuralstructuretreatmentviruswhitezanamivir
Loading